Patrys Limited (PAB.AX)

AUD 0.0

(0.0%)

EBITDA Summary of Patrys Limited

  • Patrys Limited's latest annual EBITDA in 2024 was -3.49 Million AUD , up 64.33% from previous year.
  • Patrys Limited's latest quarterly EBITDA in 2024 FY was N/A , up 50.34% from previous quarter.
  • Patrys Limited reported an annual EBITDA of -9.78 Million AUD in 2023, up 13.36% from previous year.
  • Patrys Limited reported an annual EBITDA of -11.52 Million AUD in 2022, down -94.96% from previous year.
  • Patrys Limited reported a quarterly EBITDA of N/A for 2024 FY, up 50.34% from previous quarter.
  • Patrys Limited reported a quarterly EBITDA of -1.56 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Patrys Limited (2024 - 2007)

Historical Annual EBITDA of Patrys Limited (2024 - 2007)

Year EBITDA EBITDA Growth
2024 -3.49 Million AUD 64.33%
2023 -9.78 Million AUD 13.36%
2022 -11.52 Million AUD -94.96%
2021 -5.68 Million AUD -68.6%
2020 -3.32 Million AUD -2.47%
2019 -3.36 Million AUD -37.3%
2018 -2.9 Million AUD -5.93%
2017 -1.42 Million AUD -35.87%
2016 -1.56 Million AUD -386.93%
2015 -2.88 Million AUD 95.65%
2014 -7.31 Million AUD -71.24%
2013 -4.69 Million AUD 23.84%
2012 -6.16 Million AUD 0.15%
2011 -6.39 Million AUD 3.9%
2010 -6.42 Million AUD 19.47%
2009 -7.94 Million AUD -9.33%
2008 -6.93 Million AUD 0.0%
2007 - AUD 0.0%

Peer EBITDA Comparison of Patrys Limited

Name EBITDA EBITDA Difference
EZZ Life Science Holdings Limited 10.37 Million AUD 133.658%
Anatara Lifesciences Ltd -1.45 Million AUD -139.736%
Zelira Therapeutics Limited -36.44 Million AUD 90.417%
Biome Australia Limited -1.57 Million AUD -121.267%
Orthocell Limited -11.68 Million AUD 70.104%
Imugene Limited -147.97 Million AUD 97.64%
Noxopharm Limited -5.94 Million AUD 41.264%
PYC Therapeutics Limited -38.11 Million AUD 90.838%
Chimeric Therapeutics Limited -11.29 Million AUD 69.095%
Prescient Therapeutics Limited -7.18 Million AUD 51.401%
Proteomics International Laboratories Limited -7.88 Million AUD 55.724%
Cynata Therapeutics Limited -9.95 Million AUD 64.904%
CSL Limited 4.73 Billion AUD 100.074%
Arovella Therapeutics Limited -8.83 Million AUD 60.465%
Bio-Gene Technology Limited -2.97 Million AUD -17.384%
Clinuvel Pharmaceuticals Limited 51.86 Million AUD 106.733%
Starpharma Holdings Limited -12.57 Million AUD 72.234%
Nanollose Limited -1.14 Million AUD -204.221%
Memphasys Limited -3.3 Million AUD -5.576%
Invex Therapeutics Ltd -720.44 Thousand AUD -384.724%
NeuroScientific Biopharmaceuticals Limited -1.79 Million AUD -94.41%
Amplia Therapeutics Limited -4.55 Million AUD 23.411%
Botanix Pharmaceuticals Limited -13.91 Million AUD 74.912%
Island Pharmaceuticals Limited -2.81 Million AUD -23.918%
Race Oncology Limited -14.2 Million AUD 75.413%
Nyrada Inc. -4.59 Million AUD 24.021%
Telix Pharmaceuticals Limited 22.96 Million AUD 115.206%
Dimerix Limited -24.95 Million AUD 86.008%
PharmAust Limited -9.45 Million AUD 63.053%
Immutep Limited -42.87 Million AUD 91.855%
Clarity Pharmaceuticals Ltd -44.64 Million AUD 92.178%
Alterity Therapeutics Limited -19.57 Million AUD 82.157%
BTC Health Limited 1.05 Million AUD 430.92%
Acrux Limited -7.93 Million AUD 55.968%
Neuren Pharmaceuticals Limited 199.26 Million AUD 101.753%
Biotron Limited -5.04 Million AUD 30.712%
Tissue Repair Ltd -5.77 Million AUD 39.53%
AdAlta Limited -5.3 Million AUD 34.144%
Radiopharm Theranostics Limited -45.37 Million AUD 92.304%
Hexima Limited -995.54 Thousand AUD -250.779%
AnteoTech Limited -11.57 Million AUD 69.82%
Paradigm Biopharmaceuticals Limited -64.53 Million AUD 94.589%
Recce Pharmaceuticals Ltd -21.35 Million AUD 83.646%
Avecho Biotechnology Limited -3.24 Million AUD -7.699%
Actinogen Medical Limited -12.92 Million AUD 72.973%
Immuron Limited -6.19 Million AUD 43.605%
Argenica Therapeutics Limited -1.89 Million AUD -84.031%